Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jayashree Kalpathy-Cramer

Concepts (397)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Artificial Intelligence
38
2025
282
5.820
Why?
Retinopathy of Prematurity
34
2024
142
5.790
Why?
Image Processing, Computer-Assisted
22
2025
754
3.240
Why?
Brain Neoplasms
23
2024
1239
3.170
Why?
Glioblastoma
15
2024
346
3.160
Why?
Algorithms
38
2024
1704
2.490
Why?
Diagnostic Imaging
19
2024
332
2.230
Why?
Machine Learning
21
2024
505
2.210
Why?
Radiology
10
2024
180
1.940
Why?
Natural Language Processing
7
2023
95
1.910
Why?
Magnetic Resonance Imaging
41
2024
3577
1.900
Why?
Information Storage and Retrieval
8
2015
118
1.740
Why?
Uterine Cervical Neoplasms
7
2025
257
1.730
Why?
Neuroimaging
7
2022
260
1.570
Why?
Glioma
8
2022
395
1.460
Why?
Radiotherapy Planning, Computer-Assisted
5
2016
130
1.310
Why?
Image Interpretation, Computer-Assisted
13
2025
267
1.240
Why?
Papillomavirus Infections
5
2025
325
1.150
Why?
Software
10
2024
665
1.100
Why?
Optic Disk
2
2025
45
1.010
Why?
Humans
158
2025
137782
0.970
Why?
Glaucoma
2
2025
237
0.910
Why?
Tomography, X-Ray Computed
15
2023
2697
0.910
Why?
ROC Curve
15
2024
554
0.880
Why?
Severity of Illness Index
9
2024
2836
0.880
Why?
Telemedicine
7
2023
862
0.870
Why?
Tomography, Optical Coherence
2
2025
213
0.870
Why?
Reproducibility of Results
28
2025
3290
0.840
Why?
Ophthalmology
5
2023
86
0.810
Why?
Radiology Information Systems
4
2022
30
0.800
Why?
Solitary Pulmonary Nodule
3
2021
22
0.800
Why?
Privacy
1
2023
42
0.800
Why?
Retina
6
2023
298
0.790
Why?
Breast Neoplasms
7
2024
2253
0.790
Why?
Diagnostic Techniques, Ophthalmological
3
2018
40
0.780
Why?
Infant, Newborn
34
2024
6084
0.740
Why?
Radiologists
4
2024
51
0.730
Why?
Ophthalmoscopy
8
2024
36
0.720
Why?
Gestational Age
17
2024
910
0.680
Why?
Sensitivity and Specificity
14
2024
1946
0.670
Why?
Crowdsourcing
1
2020
17
0.670
Why?
Fundus Oculi
5
2025
65
0.650
Why?
Retinal Vessels
6
2024
69
0.640
Why?
Medicine
1
2021
121
0.640
Why?
Breast Density
3
2024
6
0.620
Why?
Mammography
4
2024
154
0.600
Why?
Stroke
3
2023
1120
0.590
Why?
Retrospective Studies
26
2025
15682
0.560
Why?
Retinal Vein
4
2021
13
0.560
Why?
Isocitrate Dehydrogenase
1
2017
59
0.540
Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
108
0.510
Why?
Lung Neoplasms
5
2021
2526
0.500
Why?
Tumor Burden
4
2023
309
0.500
Why?
Phenylurea Compounds
1
2016
97
0.490
Why?
Databases, Factual
8
2021
1357
0.490
Why?
Quinolines
1
2016
178
0.470
Why?
Gallbladder Neoplasms
3
2011
23
0.470
Why?
Peripheral Arterial Disease
4
2023
475
0.470
Why?
Female
56
2025
73465
0.470
Why?
Radiography, Thoracic
5
2022
167
0.460
Why?
Pattern Recognition, Automated
5
2023
73
0.460
Why?
Prostatic Neoplasms
5
2024
1043
0.460
Why?
Benchmarking
6
2024
186
0.450
Why?
Cervix Uteri
2
2025
48
0.440
Why?
Uterine Cervical Dysplasia
2
2025
42
0.440
Why?
Subtraction Technique
1
2014
23
0.440
Why?
Delivery of Health Care
1
2021
951
0.440
Why?
Photography
6
2021
96
0.430
Why?
Radiation Oncology
2
2014
82
0.430
Why?
Chemoradiotherapy
6
2018
225
0.430
Why?
Retinal Artery
3
2021
17
0.430
Why?
Early Detection of Cancer
5
2025
448
0.430
Why?
Neoplasm Recurrence, Local
2
2019
1080
0.430
Why?
Vocabulary, Controlled
1
2014
47
0.420
Why?
White Matter
3
2023
145
0.420
Why?
Phantoms, Imaging
7
2023
152
0.410
Why?
Multimodal Imaging
1
2014
114
0.400
Why?
Male
51
2025
67906
0.400
Why?
Datasets as Topic
5
2021
121
0.380
Why?
Middle Aged
31
2025
33554
0.370
Why?
Survival Analysis
4
2016
1325
0.370
Why?
Aged
29
2025
24001
0.370
Why?
Cerebral Blood Volume
3
2020
5
0.360
Why?
Radiotherapy, Conformal
1
2011
70
0.360
Why?
Contrast Media
9
2020
467
0.360
Why?
Internet
2
2014
655
0.360
Why?
Mass Screening
4
2025
1288
0.350
Why?
Clinical Competence
2
2016
1129
0.350
Why?
Adrenoleukodystrophy
2
2023
9
0.340
Why?
Brain
8
2021
2677
0.340
Why?
Proportional Hazards Models
4
2011
1266
0.340
Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
110
0.330
Why?
Precision Medicine
3
2024
433
0.320
Why?
Medical Informatics
4
2020
101
0.320
Why?
Neoplasms
7
2024
2673
0.320
Why?
Head and Neck Neoplasms
5
2020
606
0.300
Why?
Database Management Systems
1
2008
51
0.290
Why?
Endovascular Procedures
2
2023
312
0.290
Why?
User-Computer Interface
4
2015
159
0.290
Why?
Radiotherapy, Adjuvant
1
2008
220
0.280
Why?
Automation
5
2020
95
0.280
Why?
Infant, Premature
9
2024
574
0.270
Why?
Observer Variation
4
2024
343
0.270
Why?
Lung
6
2022
4060
0.270
Why?
Prognosis
9
2024
4039
0.260
Why?
Adult
26
2025
38023
0.260
Why?
Radiography
5
2022
822
0.250
Why?
Neonatal Screening
4
2023
169
0.240
Why?
Diffusion Magnetic Resonance Imaging
2
2018
154
0.240
Why?
Endoscopy, Gastrointestinal
1
2007
228
0.240
Why?
Rectal Neoplasms
2
2021
149
0.230
Why?
Predictive Value of Tests
5
2025
2041
0.230
Why?
Antineoplastic Agents
1
2016
2129
0.230
Why?
Oropharyngeal Neoplasms
2
2015
63
0.230
Why?
Reference Standards
7
2021
186
0.220
Why?
Neoplasm Grading
3
2024
307
0.220
Why?
Adenocarcinoma in Situ
1
2023
1
0.220
Why?
Forecasting
3
2019
389
0.210
Why?
Postoperative Care
2
2019
261
0.210
Why?
Statistics as Topic
2
2014
307
0.200
Why?
Ranibizumab
1
2023
20
0.200
Why?
Imaging, Three-Dimensional
4
2023
584
0.200
Why?
Macular Degeneration
1
2024
164
0.200
Why?
Oxygen
2
2021
938
0.200
Why?
Radiotherapy, Intensity-Modulated
4
2016
143
0.200
Why?
Neovascularization, Pathologic
3
2024
301
0.190
Why?
Diagnosis, Computer-Assisted
2
2021
89
0.190
Why?
Biomedical Research
3
2024
700
0.190
Why?
Documentation
2
2015
194
0.190
Why?
Long QT Syndrome
1
2023
70
0.190
Why?
Computer Communication Networks
2
2020
33
0.190
Why?
Quality Assurance, Health Care
2
2014
322
0.190
Why?
Rheumatic Diseases
1
2022
81
0.180
Why?
Infant
11
2024
9482
0.180
Why?
Diverticulitis
1
2021
8
0.180
Why?
Patient-Specific Modeling
2
2024
41
0.180
Why?
Cohort Studies
6
2022
5750
0.180
Why?
Biomarkers
4
2018
4154
0.180
Why?
Hospital Units
1
2021
29
0.170
Why?
Racism
1
2023
135
0.170
Why?
Musculoskeletal System
1
2021
48
0.170
Why?
Intestinal Obstruction
1
2021
51
0.170
Why?
India
1
2021
195
0.170
Why?
Dacarbazine
3
2015
98
0.170
Why?
Tibial Meniscus Injuries
1
2021
48
0.170
Why?
Perfusion Imaging
1
2020
58
0.170
Why?
Microcirculation
2
2017
149
0.160
Why?
Radiometry
1
2020
50
0.160
Why?
Health Information Exchange
1
2020
23
0.160
Why?
Hyperemia
1
2020
49
0.160
Why?
Cerebellar Neoplasms
1
2022
152
0.160
Why?
Medical Records Systems, Computerized
2
2013
96
0.160
Why?
Biomarkers, Tumor
3
2016
1276
0.160
Why?
Brain Ischemia
1
2023
338
0.160
Why?
Medulloblastoma
1
2022
193
0.160
Why?
Signal Processing, Computer-Assisted
2
2017
145
0.160
Why?
Lung Injury
1
2022
219
0.160
Why?
Area Under Curve
4
2021
314
0.160
Why?
Brain Diseases
1
2021
141
0.160
Why?
Positron Emission Tomography Computed Tomography
1
2020
98
0.160
Why?
Hematopoietic Stem Cell Transplantation
2
2023
622
0.160
Why?
Carcinoma, Squamous Cell
2
2015
684
0.160
Why?
Appendicitis
1
2021
130
0.160
Why?
Low Back Pain
1
2021
108
0.160
Why?
Vascular Endothelial Growth Factor A
2
2023
545
0.160
Why?
Antineoplastic Agents, Alkylating
2
2018
73
0.150
Why?
Aneurysm, Ruptured
1
2019
35
0.150
Why?
Capillary Permeability
1
2019
145
0.150
Why?
Age Determination by Skeleton
1
2018
18
0.150
Why?
Blood-Brain Barrier
2
2017
138
0.150
Why?
Drug Resistance, Neoplasm
1
2024
801
0.150
Why?
Models, Biological
4
2024
1783
0.150
Why?
Antibodies, Monoclonal, Humanized
1
2024
804
0.150
Why?
Risk Factors
8
2023
10407
0.150
Why?
Linear Models
1
2021
849
0.150
Why?
Colonic Neoplasms
1
2021
258
0.150
Why?
Cone-Beam Computed Tomography
1
2018
39
0.150
Why?
Intracranial Aneurysm
1
2019
97
0.140
Why?
Ventricular Dysfunction, Right
1
2021
238
0.140
Why?
Arteries
2
2019
269
0.140
Why?
Medical Record Linkage
1
2018
65
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1692
0.140
Why?
Prospective Studies
7
2023
7623
0.140
Why?
Global Health
1
2021
386
0.140
Why?
Respiratory Insufficiency
1
2021
318
0.140
Why?
Treatment Outcome
7
2023
10837
0.140
Why?
Bayes Theorem
2
2016
407
0.140
Why?
Polysaccharides, Bacterial
1
2017
70
0.140
Why?
Gadolinium
1
2017
82
0.140
Why?
Preoperative Period
1
2017
129
0.140
Why?
Diagnosis, Differential
3
2019
1483
0.130
Why?
Gray Matter
1
2018
80
0.130
Why?
Patient Readmission
1
2022
698
0.130
Why?
North America
3
2024
313
0.130
Why?
Chronic Pain
1
2021
265
0.130
Why?
Computer Simulation
5
2024
982
0.130
Why?
Skin Diseases, Genetic
1
2016
12
0.130
Why?
Pharyngeal Muscles
1
2016
5
0.130
Why?
Nasopharyngeal Neoplasms
1
2016
21
0.120
Why?
Blood Vessels
1
2017
187
0.120
Why?
SEER Program
3
2011
227
0.120
Why?
Angiogenesis Inhibitors
2
2016
229
0.120
Why?
National Cancer Institute (U.S.)
3
2020
49
0.120
Why?
Blood Volume Determination
1
2015
5
0.120
Why?
Vascular Malformations
1
2016
52
0.120
Why?
Risk Assessment
4
2025
3461
0.120
Why?
Acute Kidney Injury
1
2023
815
0.120
Why?
Liver Cirrhosis
1
2017
316
0.120
Why?
Positron-Emission Tomography
4
2021
295
0.120
Why?
Cranial Irradiation
1
2015
70
0.120
Why?
Fibrosis
1
2017
552
0.110
Why?
Physical Phenomena
1
2014
13
0.110
Why?
Organs at Risk
1
2014
32
0.110
Why?
Aged, 80 and over
5
2018
7637
0.110
Why?
Societies, Medical
3
2024
820
0.110
Why?
Radiation Injuries
1
2016
145
0.110
Why?
Longitudinal Studies
2
2019
2860
0.110
Why?
Brachial Plexus
1
2014
29
0.110
Why?
Tumor Microenvironment
1
2018
676
0.110
Why?
Birth Weight
3
2023
516
0.110
Why?
Administration, Oral
1
2016
816
0.110
Why?
Chemoradiotherapy, Adjuvant
2
2011
43
0.110
Why?
Deglutition Disorders
1
2016
143
0.110
Why?
Joint Instability
1
2016
167
0.110
Why?
Mutation
3
2024
3959
0.100
Why?
Computer-Assisted Instruction
1
2014
66
0.100
Why?
Arteriovenous Malformations
1
2013
27
0.100
Why?
Bias
3
2024
218
0.100
Why?
Computer Literacy
1
2013
5
0.100
Why?
Health Information Systems
1
2013
17
0.100
Why?
Young Adult
7
2018
13240
0.100
Why?
Terminology as Topic
1
2014
216
0.100
Why?
Survival Rate
3
2018
1973
0.100
Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.090
Why?
Feasibility Studies
2
2014
963
0.090
Why?
Nomograms
1
2011
54
0.090
Why?
Workload
1
2013
167
0.090
Why?
Research Design
2
2014
1139
0.090
Why?
Child
8
2024
21989
0.080
Why?
Support Vector Machine
2
2021
38
0.080
Why?
Muscle, Skeletal
1
2020
1724
0.080
Why?
Emergency Service, Hospital
1
2021
2072
0.080
Why?
Periodicals as Topic
1
2012
211
0.080
Why?
Papillomaviridae
2
2023
125
0.080
Why?
Liver
1
2017
1943
0.080
Why?
Oregon
1
2008
74
0.070
Why?
United States
5
2024
14870
0.070
Why?
Exercise
1
2020
2061
0.070
Why?
Total Quality Management
1
2008
61
0.070
Why?
Lower Extremity
2
2023
434
0.070
Why?
MEDLINE
1
2008
21
0.070
Why?
Follow-Up Studies
3
2024
5136
0.070
Why?
Dilatation, Pathologic
2
2018
62
0.070
Why?
Breast
2
2019
151
0.070
Why?
Protein Kinase Inhibitors
1
2013
916
0.070
Why?
Electronic Health Records
1
2015
1070
0.070
Why?
Monte Carlo Method
2
2017
148
0.060
Why?
Cluster Analysis
1
2007
501
0.060
Why?
Clinical Protocols
2
2019
271
0.060
Why?
Tanzania
1
2025
58
0.060
Why?
Vaginal Smears
1
2025
57
0.060
Why?
Critical Illness
2
2021
815
0.060
Why?
Proof of Concept Study
1
2024
78
0.060
Why?
Netherlands
1
2024
88
0.050
Why?
Intensive Care Units, Neonatal
2
2018
257
0.050
Why?
Physicians
1
2013
914
0.050
Why?
Kinetics
2
2019
1670
0.050
Why?
Colposcopy
1
2023
18
0.050
Why?
Brain Infarction
1
2023
23
0.050
Why?
DNA, Viral
1
2025
364
0.050
Why?
Troponin T
1
2023
65
0.050
Why?
Models, Theoretical
2
2021
578
0.050
Why?
X-Rays
1
2022
28
0.050
Why?
DNA Helicases
1
2024
145
0.050
Why?
Data Curation
1
2022
17
0.050
Why?
Smartphone
1
2023
91
0.050
Why?
Adrenal Glands
1
2022
78
0.050
Why?
Cross-Sectional Studies
2
2024
5478
0.050
Why?
Quinazolines
2
2013
251
0.050
Why?
Logistic Models
2
2021
2075
0.050
Why?
Limb Salvage
1
2022
57
0.050
Why?
Health Services
1
2022
107
0.050
Why?
Antineoplastic Agents, Immunological
1
2024
190
0.050
Why?
Vagina
1
2024
187
0.050
Why?
Utilization Review
1
2021
36
0.040
Why?
Receptors, GABA
1
2021
14
0.040
Why?
Edema
1
2022
130
0.040
Why?
Nepal
1
2021
30
0.040
Why?
Neoadjuvant Therapy
1
2024
404
0.040
Why?
Genetic Therapy
1
2023
297
0.040
Why?
Massachusetts
1
2021
172
0.040
Why?
Case-Control Studies
2
2019
3569
0.040
Why?
Clinical Trials as Topic
2
2016
1052
0.040
Why?
Early Diagnosis
1
2021
242
0.040
Why?
Abdomen
1
2021
125
0.040
Why?
Seizures
1
2024
426
0.040
Why?
Genotype
1
2025
1917
0.040
Why?
Incidence
2
2020
2804
0.040
Why?
Internationality
1
2021
155
0.040
Why?
Cell Cycle Proteins
1
2024
617
0.040
Why?
Ankle
1
2020
60
0.040
Why?
Models, Statistical
2
2016
669
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
28
0.040
Why?
Hematopoietic Stem Cells
1
2023
406
0.040
Why?
Disease Progression
2
2020
2760
0.040
Why?
Hand Bones
1
2018
2
0.040
Why?
Infant, Low Birth Weight
1
2020
141
0.040
Why?
Nuclear Proteins
1
2024
712
0.040
Why?
Risk
1
2021
912
0.040
Why?
Arthroscopy
1
2021
222
0.040
Why?
Bevacizumab
1
2019
138
0.040
Why?
Quality Control
1
2019
172
0.040
Why?
Radiation Exposure
1
2019
49
0.040
Why?
Medical Oncology
1
2021
293
0.040
Why?
Ventricular Function, Right
1
2021
285
0.040
Why?
Genomics
1
2024
795
0.040
Why?
Hyperlipidemias
1
2019
120
0.040
Why?
Reference Values
1
2020
816
0.040
Why?
Hemizygote
1
2017
5
0.040
Why?
Carbon Tetrachloride
1
2017
13
0.040
Why?
Diabetic Retinopathy
1
2020
189
0.040
Why?
Half-Life
1
2017
164
0.030
Why?
Skull
1
2018
139
0.030
Why?
Diffusion
1
2017
116
0.030
Why?
Permeability
1
2017
161
0.030
Why?
Chemotherapy, Adjuvant
1
2018
389
0.030
Why?
Consensus
1
2020
683
0.030
Why?
Outpatients
1
2021
397
0.030
Why?
Asymptomatic Diseases
1
2017
89
0.030
Why?
Ecosystem
1
2022
596
0.030
Why?
Tissue Distribution
1
2017
332
0.030
Why?
Information Dissemination
1
2019
218
0.030
Why?
Signal-To-Noise Ratio
1
2016
67
0.030
Why?
Expert Systems
1
2016
3
0.030
Why?
Respiration, Artificial
1
2021
645
0.030
Why?
Prostate
1
2017
175
0.030
Why?
Palate, Soft
1
2016
15
0.030
Why?
Video Recording
1
2017
180
0.030
Why?
Heart Ventricles
1
2021
790
0.030
Why?
Dose-Response Relationship, Radiation
1
2016
141
0.030
Why?
Evaluation Studies as Topic
1
2016
180
0.030
Why?
Antineoplastic Protocols
1
2015
1
0.030
Why?
Transcription Factors
1
2024
1719
0.030
Why?
Magnetic Resonance Angiography
1
2017
240
0.030
Why?
Perfusion
1
2016
214
0.030
Why?
Platelet Count
1
2015
86
0.030
Why?
Molecular Imaging
1
2016
56
0.030
Why?
Radiotherapy Dosage
1
2016
268
0.030
Why?
Cerebrovascular Circulation
1
2017
250
0.030
Why?
Motion
1
2015
99
0.030
Why?
Disease-Free Survival
1
2016
686
0.030
Why?
Intensive Care Units
1
2021
832
0.030
Why?
Diffusion Tensor Imaging
1
2015
79
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1478
0.030
Why?
Thoracic Neoplasms
1
2014
37
0.030
Why?
Comorbidity
1
2019
1623
0.030
Why?
Mass Spectrometry
1
2017
739
0.030
Why?
Image Enhancement
1
2015
190
0.030
Why?
DNA Modification Methylases
1
2013
17
0.030
Why?
Carcinoma
1
2016
240
0.030
Why?
DNA Repair Enzymes
1
2013
28
0.030
Why?
Congresses as Topic
1
2015
232
0.030
Why?
Child, Preschool
2
2018
11105
0.030
Why?
Argentina
1
2013
26
0.030
Why?
Pandemics
1
2021
1639
0.020
Why?
Molecular Targeted Therapy
1
2016
411
0.020
Why?
Statistics, Nonparametric
1
2013
431
0.020
Why?
Fluorescein Angiography
1
2013
151
0.020
Why?
Adolescent
3
2018
21574
0.020
Why?
Life Tables
1
2011
20
0.020
Why?
Receptor Protein-Tyrosine Kinases
1
2013
234
0.020
Why?
Effect Modifier, Epidemiologic
1
2011
12
0.020
Why?
Hemodynamics
1
2016
1113
0.020
Why?
Smoking
1
2019
1627
0.020
Why?
Tumor Suppressor Proteins
1
2013
327
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2013
853
0.020
Why?
Time Factors
1
2022
6834
0.020
Why?
Hospitalization
1
2021
2200
0.020
Why?
Pregnancy
1
2023
6771
0.020
Why?
Diabetes Mellitus
1
2019
1041
0.020
Why?
Polymerase Chain Reaction
1
2013
1062
0.020
Why?
Probability
1
2011
304
0.020
Why?
Educational Status
1
2013
470
0.020
Why?
Pilot Projects
1
2015
1713
0.020
Why?
Hypertension
1
2019
1298
0.020
Why?
Lymphatic Metastasis
1
2011
352
0.020
Why?
Kaplan-Meier Estimate
1
2011
889
0.020
Why?
Rats
1
2017
5648
0.020
Why?
PubMed
1
2008
11
0.020
Why?
Ultrasonography
1
2012
763
0.020
Why?
Disease Models, Animal
1
2017
4295
0.020
Why?
Neoplasm Staging
1
2011
1389
0.020
Why?
Attitude of Health Personnel
1
2013
1172
0.010
Why?
Internship and Residency
1
2014
1151
0.010
Why?
Age Factors
1
2011
3305
0.010
Why?
Mice
1
2017
17794
0.010
Why?
Animals
1
2017
36951
0.010
Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)